Teleflex Inc. (TFX): Price and Financial Metrics
GET POWR RATINGS... FREE!
TFX Price/Volume Stats
| Current price | $232.35 | 52-week high | $290.95 |
| Prev. close | $233.17 | 52-week low | $182.65 |
| Day low | $231.92 | Volume | 186,400 |
| Day high | $235.34 | Avg. volume | 316,891 |
| 50-day MA | $254.05 | Dividend yield | 0.58% |
| 200-day MA | $235.89 | Market Cap | 10.90B |
TFX Stock Price Chart Interactive Chart >
TFX POWR Grades
- Growth is the dimension where TFX ranks best; there it ranks ahead of 84.15% of US stocks.
- TFX's strongest trending metric is Growth; it's been moving up over the last 179 days.
- TFX's current lowest rank is in the Sentiment metric (where it is better than 32.49% of US stocks).
TFX Stock Summary
- With a market capitalization of $10,948,634,252, TELEFLEX INC has a greater market value than 85.51% of US stocks.
- TELEFLEX INC's stock had its IPO on February 18, 1988, making it an older stock than 90.47% of US equities in our set.
- The price/operating cash flow metric for TELEFLEX INC is higher than 85.7% of stocks in our set with a positive cash flow.
- Stocks that are quantitatively similar to TFX, based on their financial statements, market capitalization, and price volatility, are CW, HUN, VTRS, SSD, and XYL.
- TFX's SEC filings can be seen here. And to visit TELEFLEX INC's official web site, go to www.teleflex.com.
TFX Valuation Summary
- In comparison to the median Healthcare stock, TFX's EV/EBIT ratio is 105.83% higher, now standing at 24.7.
- Over the past 243 months, TFX's EV/EBIT ratio has gone up 14.2.
Below are key valuation metrics over time for TFX.
| Stock | Date | P/S | P/B | P/E | EV/EBIT |
|---|---|---|---|---|---|
| TFX | 2023-05-23 | 3.9 | 2.7 | 30.7 | 24.7 |
| TFX | 2023-05-22 | 4.0 | 2.8 | 31.8 | 25.4 |
| TFX | 2023-05-19 | 4.0 | 2.8 | 31.6 | 25.3 |
| TFX | 2023-05-18 | 4.0 | 2.8 | 31.7 | 25.4 |
| TFX | 2023-05-17 | 4.0 | 2.8 | 31.8 | 25.4 |
| TFX | 2023-05-16 | 4.1 | 2.8 | 31.9 | 25.5 |
TFX Growth Metrics
- Its 3 year net income to common stockholders growth rate is now at 162.86%.
- Its 4 year revenue growth rate is now at 35.29%.
- Its 4 year net cashflow from operations growth rate is now at -15.81%.
The table below shows TFX's growth in key financial areas (numbers in millions of US dollars).
| Date | Revenue | Operating Cash Flow | Net Income to Common Stock |
|---|---|---|---|
| 2022-09-30 | 2,794.959 | 445.411 | 412.629 |
| 2022-06-30 | 2,808.422 | 488.294 | 509.915 |
| 2022-03-31 | 2,817.353 | 602.851 | 487.649 |
| 2021-12-31 | 2,809.563 | 651.419 | 485.374 |
| 2021-09-30 | 2,758.828 | 645.399 | 433.426 |
| 2021-06-30 | 2,686.878 | 567.418 | 350.832 |
TFX's Quality Factors
The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.- TFX has a Quality Grade of C, ranking ahead of 64.94% of graded US stocks.
- TFX's asset turnover comes in at 0.39 -- ranking 117th of 186 Medical Equipment stocks.
- MDT, XRAY, and TNDM are the stocks whose asset turnover ratios are most correlated with TFX.
The table below shows TFX's key quality metrics over time.
| Period | Asset Turnover | Gross Margin | ROIC |
|---|---|---|---|
| 2021-09-26 | 0.390 | 0.549 | 0.156 |
| 2021-06-27 | 0.386 | 0.542 | 0.124 |
| 2021-03-28 | 0.369 | 0.526 | 0.103 |
| 2020-12-31 | 0.373 | 0.522 | 0.117 |
| 2020-09-27 | 0.380 | 0.534 | 0.129 |
| 2020-06-28 | 0.388 | 0.548 | 0.127 |
TFX Price Target
For more insight on analysts targets of TFX, see our TFX price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.
| Average Price Target | $462.55 | Average Broker Recommendation | 1.5 (Moderate Buy) |
Teleflex Inc. (TFX) Company Bio
Teleflex Incorporated, headquartered in Wayne, Pennsylvania, is an American provider of specialty medical devices for a range of procedures in critical care and surgery. Teleflex has annual revenues of $2.4 billion, operations in 40 countries, and more than 12,000 employees. By 2011, the company had substantially realigned to focus on its current business as a medical-device manufacturer, having undergone several years of active acquisitions and divestitures. Teleflex has been associated with Irish corporate tax avoidance tools. Teleflex's current chief executive officer (CEO) is Liam J. Kelly, who took over from Benson F. Smith at the start of 2018; Kelly is also the company's president and former chief operating officer. (Source:Wikipedia)
Latest TFX News From Around the Web
Below are the latest news stories about TELEFLEX INC that investors may wish to consider to help them evaluate TFX as an investment opportunity.
Teleflex Publishes 2022 Global Impact ReportHighlights Accomplishments and Sets Goals for Corporate Social Responsibility ProgramWAYNE, Pa., May 15, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies, today announced it has published its 2022 Global Impact Report. The report outlines recent accomplishments and sets new targets to support the company’s Corporate Social Responsibility (CSR) program and aligns with the Global Reporting Initiative (GRI), the Sustainability Accounting |
An Intrinsic Calculation For Teleflex Incorporated (NYSE:TFX) Suggests It's 20% UndervaluedKey Insights Using the 2 Stage Free Cash Flow to Equity, Teleflex fair value estimate is US$324 Current share price of... |
Teleflex (TFX) Q1 Earnings Top Estimates, 2023 Sales View UpTeleflex (TFX) registers growth across the majority of its businesses, including double-digit increases in interventional and surgical revenues in Q1. |
Teleflex Announces Quarterly DividendWAYNE, Pa., May 08, 2023 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX) announced today that its Board of Directors declared a quarterly cash dividend of thirty-four cents ($0.34) per share of common stock. The dividend is payable June 15, 2023, to shareholders of record at the close of business on May 15, 2023. Additional information about Teleflex can be obtained from the company’s website at teleflex.com. About Teleflex IncorporatedTeleflex is a global provider of medical technologies |
Teleflex (TFX) Reports Q1 Earnings: What Key Metrics Have to SayWhile the top- and bottom-line numbers for Teleflex (TFX) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. |
TFX Price Returns
| 1-mo | -14.62% |
| 3-mo | -2.19% |
| 6-mo | -0.48% |
| 1-year | -19.45% |
| 3-year | -35.10% |
| 5-year | -10.96% |
| YTD | -6.66% |
| 2022 | -23.61% |
| 2021 | -19.89% |
| 2020 | 9.75% |
| 2019 | 46.26% |
| 2018 | 4.45% |
TFX Dividends
| Ex-Dividend Date | Type | Payout Amount | Change | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
Continue Researching TFX
Want to see what other sources are saying about Teleflex Inc's financials and stock price? Try the links below:Teleflex Inc (TFX) Stock Price | Nasdaq
Teleflex Inc (TFX) Stock Quote, History and News - Yahoo Finance
Teleflex Inc (TFX) Stock Price and Basic Information | MarketWatch
Loading social stream, please wait...